Phreesia, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Phreesia, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 29.7 times by its yearly operating cash. Higher than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Jan 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
1.1×Over the last 3 years its own operating cash covered its investment spending (capex) 1.1 times.
Higher than 68% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$89Sales grew 71% in 3 years; of every extra $100 of sales, $89 became extra profit.
Higher than 79% of Healthcare companies in United States.
Asset Productivity Ratio
+71% / +79%In 3 years sales changed by +71% while total assets changed by +79%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
29.7×Debt due within a year is covered 29.7 times by its yearly operating cash.
Higher than 92% of Healthcare companies in United States.
Cash Cushion Ratio
−4%Debt, after subtracting cash, equals 4% of its market value (net debt).
Lower than 72% of Healthcare companies in United States.
Tangible Assets Ratio
54%Of every $100 the company owns, $54 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 75% of Healthcare companies in United States.
Tangible Net Worth Ratio
10%Of every $100 of net worth, $10 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 69% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Phreesia, Inc. owes $0.43 for every $1 it owns. Phreesia, Inc. returned to profit in the year to Jan 2026, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Jan 2026.
P/E ratio
74.8Investors pay $74.8 for every $1 of Phreesia, Inc.'s yearly profit, higher than 86% of Healthcare companies in United States.
P/B ratio
2.12The share price is 2.12 times Phreesia, Inc.'s book value per share, lower than 56% of Healthcare companies in United States.
Market cap
$790 MThe total market value of all of Phreesia, Inc.'s shares at today's price (share price × number of shares), larger than 61% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$372 MWhat Phreesia, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Jul 2026).
Book value per share
$5.99Net worth divided by the number of shares. The share price of $12.72 is 2.1 times this, which is the P/B above.
Return on equity (ROE)
3.1%Phreesia, Inc. earned 3.1% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
Owes vs Owns
0.43×Phreesia, Inc. owes $0.43 for every $1 it owns (low), higher than 50% of Healthcare companies in United States.
Dividend yield
NonePhreesia, Inc. does not currently pay a dividend.
Revenue growth
+14%Revenue rose 14% in the year to Jan 2026, and grew 20% a year on average over 3 years.
Profit growth
Back to profitPhreesia, Inc. returned to profit in the year to Jan 2026, after a loss the year before.
Profit margin
0.5%Phreesia, Inc. keeps $0 of every $100 of revenue as net profit.
Cash quality
34.2×Cash from Phreesia, Inc.'s business was 34.2× its reported profit in the year to Jan 2026 — its profit turned into cash.
Interest cover
Not coveredPhreesia, Inc.'s operating profit did not cover its interest costs in the year to Jan 2026.
Cash vs debt
Net debtPhreesia, Inc. had $29 M more debt than cash (net debt) at Jan 2026.
Questions
What is Phreesia, Inc.'s P/E ratio?
Investors pay $74.8 for every $1 of Phreesia, Inc.'s yearly profit, higher than 86% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Phreesia, Inc.: $790 M ÷ $372 M (31 Jul 2026) = 2.1.
What is Phreesia, Inc.'s return on equity?
Phreesia, Inc. earned 3.1% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
How much does Phreesia, Inc. owe compared with what it owns?
Phreesia, Inc. owes $0.43 for every $1 it owns (low), higher than 50% of Healthcare companies in United States.
Does Phreesia, Inc. pay a dividend?
No. Phreesia, Inc. does not currently pay a dividend.
Is Phreesia, Inc.'s revenue growing?
Revenue rose 14% in the year to Jan 2026, and grew 20% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.